Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Indian Journal of Pediatrics

07-09-2023 | Juvenile Rheumatoid Arthritis | Review Article

Basic Investigations in Pediatric Rheumatology

Authors: Aaqib Zaffar Banday, Rahila Nisar, Pratap Kumar Patra, Imtiyaz Ahmad, Anju Gupta

Published in: Indian Journal of Pediatrics

Login to get access

Abstract

The spectrum of pediatric rheumatological disorders is diverse and they are important differential diagnoses in a variety of clinical scenarios. Basic investigations not only provide supporting evidence for the diagnosis of a rheumatological illness but also help in exclusion of other diseases as well as for monitoring the activity of disease. Among these, complete blood count, biochemical assays including tests for inflammatory response, urine analysis, and various autoantibodies are often used. In addition, depending on the clinical features, imaging and tissue biopsies are used to confirm the diagnosis.
Literature
1.
2.
3.
Swaak A. Anemia of chronic disease in patients with rheumatoid arthritis: aspects of prevalence, outcome, diagnosis, and the effect of treatment on disease activity. J Rheumatol. 2006;33:1467–8.PubMed
4.
Kasap-Demir B, Bayram G, Önder-Siviş Z, Güneş-Tatlı B, Anıl BA. Diffuse alveolar hemorrhage as a life-threatening feature of juvenile onset systemic lupus erythematosus: a case-based review. Mediterr J Rheumatol. 2022;33:81–7.CrossRefPubMedPubMedCentral
5.
Lu Y, Huang XM. Autoimmune haemolytic anemia as an initial presentation in children with systemic lupus erythematosus: two case reports. J Int Med Res. 2022;50:03000605221115390.CrossRefPubMedPubMedCentral
6.
Ferrara G, Mastrangelo G, Barone P, et al. Methotrexate in juvenile idiopathic arthritis: advice and recommendations from the MARAJIA expert consensus meeting. Pediatr Rheumatol Online J. 2018;16:46.CrossRefPubMedPubMedCentral
7.
Ravelli A, Minoia F, Davì S, et al. 2016 classification criteria for macrophage activation syndrome complicating systemic juvenile idiopathic arthritis: A European League Against Rheumatism/American College of Rheumatology/Paediatric Rheumatology International Trials Organisation Collaborative Initiative. Arthritis Rheumatol. 2016;68:566–76.CrossRefPubMed
8.
9.
10.
McCann LJ, Juggins AD, Maillard SM, et al. The Juvenile Dermatomyositis National Registry and Repository (UK and Ireland)–clinical characteristics of children recruited within the first 5 yr. Rheumatology (Oxford). 2006;45:1255–60.CrossRefPubMed
11.
Masuda H, Ae R, Koshimizu TA, et al. Serum sodium level associated with coronary artery lesions in patients with Kawasaki disease. Clin Rheumatol. 2022;41:137–45.CrossRefPubMed
12.
Mărginean CO, Meliţ LE, Grigorescu G, Puiac C, Simu I. Hypercalcemia, an important puzzle piece in uncommon onset pediatric sarcoidosis- A case report and a review of the literature. Front Pediatr. 2020;8:497.CrossRefPubMedPubMedCentral
13.
Wedderburn LR, Rider LG. Juvenile dermatomyositis: new developments in pathogenesis, assessment and treatment. Best Pract Res Clin Rheumatol. 2009;23:665–78.CrossRefPubMedPubMedCentral
14.
15.
Minoia F, Davì S, Horne A, et al. Clinical features, treatment, and outcome of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis: a multinational, multicenter study of 362 patients. Arthritis Rheumatol. 2014;66:3160–9.CrossRefPubMed
16.
Devreese KMJ, de Groot PG, de Laat B, et al. Guidance from the Scientific and Standardization Committee for lupus anticoagulant/antiphospholipid antibodies of the International Society on Thrombosis and Haemostasis: update of the guidelines for lupus anticoagulant detection and interpretation. J Thromb Haemost. 2020;18:2828–39.CrossRefPubMed
17.
Mulliez SM, De Keyser F, Verbist C, et al. Lupus anticoagulant-hypoprothrombinemia syndrome: report of two cases and review of the literature. Lupus. 2015;24:736–45.CrossRefPubMed
18.
19.
Mackay IR. Travels and travails of autoimmunity: a historical journey from discovery to rediscovery. Autoimmun Rev. 2010;9:A251–8.CrossRefPubMed
20.
Song YW, Kang EH. Autoantibodies in rheumatoid arthritis: rheumatoid factors and anticitrullinated protein antibodies. QJM. 2010;103:139–46.CrossRefPubMed
21.
Keren DF. Autoimmune disease. In: Wild D, editor. The Immunoassay Handbook. 4th ed. Oxford (UK): Elsevier; 2013. p. 869–90.CrossRef
22.
Chan EKL, von Mühlen CA, Fritzler MJ, et al. The International Consensus on ANA Patterns (ICAP) in 2021-The 6th workshop and current perspectives. J Appl Lab Med. 2022;7:322–30.CrossRefPubMed
23.
Chan EK, Damoiseaux J, Carballo OG, et al. Report of the first international consensus on standardized nomenclature of antinuclear antibody HEp-2 cell patterns 2014–2015. Front Immunol. 2015;6:412.CrossRefPubMedPubMedCentral
24.
Alsaed OS, Alamlih LI, Al-Radideh O, Chandra P, Alemadi S, Al-Allaf AW. Clinical utility of ANA-ELISA vs ANA-immunofluorescence in connective tissue diseases. Sci Rep. 2021;11:8229.CrossRefPubMedPubMedCentral
25.
Jaeggi E, Laskin C, Hamilton R, Kingdom J, Silverman E. The importance of the level of maternal anti-Ro/SSA antibodies as a prognostic marker of the development of cardiac neonatal lupus erythematosus a prospective study of 186 antibody-exposed fetuses and infants. J Am Coll Cardiol. 2010;55:2778–84.CrossRefPubMed
26.
Yuan W, Cao H, Li W, Wu X, Zheng J. Comparison study of bead-based and line-blot multiplex ANA immunoassays in the diagnosis of systemic autoimmune rheumatic diseases. Clin Rheumatol. 2022;41:899–909.CrossRefPubMed
27.
Kim Y, Park Y, Lee EY, Kim HS. Comparison of automated multiplexed bead-based ANA screening assay with ELISA for detecting five common anti-extractable nuclear antigens and anti-dsDNA in systemic rheumatic diseases. Clin Chim Acta. 2012;413:308–11.CrossRefPubMed
28.
Cabral DA, Canter DL, Muscal E, et al. Comparing presenting clinical features in 48 children with microscopic polyangiitis to 183 children who have granulomatosis with polyangiitis (Wegener’s): An ARChiVe cohort study. Arthritis Rheumatol. 2016;68:2514–26.CrossRefPubMed
29.
van Beers JJBC, Vanderlocht J, Roozendaal C, Damoiseaux J. Detection of anti-neutrophil cytoplasmic antibodies (ANCA) by indirect immunofluorescence. Methods Mol Biol. 2019;1901:47–62.CrossRefPubMed
30.
Moiseev S, Cohen Tervaert JW, Arimura Y, et al. 2020 international consensus on ANCA testing beyond systemic vasculitis. Autoimmun Rev. 2020;19:102618.
31.
Tomasson G, Grayson PC, Mahr AD, Lavalley M, Merkel PA. Value of ANCA measurements during remission to predict a relapse of ANCA-associated vasculitis–a meta-analysis. Rheumatology (Oxford). 2012;51:100–9.CrossRefPubMed
32.
Suwanchote S, Rachayon M, Rodsaward P, et al. Anti-neutrophil cytoplasmic antibodies and their clinical significance. Clin Rheumatol. 2018;37:875–84.CrossRefPubMed
33.
Bossuyt X, Cohen Tervaert JW, Arimura Y, et al. Position paper: revised 2017 international consensus on testing of ANCAs in granulomatosis with polyangiitis and microscopic polyangiitis. Nat Rev Rheumatol. 2017;13:683–92.CrossRefPubMed
34.
Yıldız M, Haşlak F, Adroviç A, Şahin S, Barut K, Kasapçopur Ö. Juvenile spondyloartropathies. Eur. J Rheumatol. 2022;9:42–9.
35.
Kuzio S, Hanguehard A, Morelle M, Ronsin C. Rapid screening for HLA-B27 by a TaqMan-PCR assay using sequence-specific primers and a minor groove binder probe, a novel type of TaqMan trade mark probe. J Immunol Methods. 2004;287:179–86.CrossRefPubMed
36.
Chheda P, Warghade S, Mathias J. HLA-B27 testing: a journey from flow cytometry to molecular subtyping. J Clin Lab Anal. 2018;32:e22382.
37.
Harayama T, Riezman H. Understanding the diversity of membrane lipid composition. Nat Rev Mol Cell Biol. 2018;19:281–96.CrossRefPubMed
38.
Miyakis S, Lockshin MD, Atsumi T, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost. 2006;4:295–306.CrossRefPubMed
39.
Tripodi A, Cohen H, Devreese KMJ. Lupus anticoagulant detection in anticoagulated patients. Guidance from the Scientific and Standardization Committee for lupus anticoagulant/antiphospholipid antibodies of the International Society on Thrombosis and Haemostasis. J Thromb Haemost. 2020;18:1569–75.
40.
Zhu FP, Luo S, Wang ZJ, Jin ZY, Zhang LJ, Lu GM. Takayasu arteritis: imaging spectrum at multidetector CT angiography. Br J Radiol. 2012;85:e1282–92.CrossRefPubMedPubMedCentral
41.
Kurugoglu S, Kanberoglu K, Kanberoglu A, Mihmanli I, Cokyuksel O. MRI appearances of inflammatory vertebral osteitis in early ankylosing spondylitis. Pediatr Radiol. 2002;32:191–4.CrossRefPubMed
42.
43.
Litwin CM, Binder SR. ANA testing in the presence of acute and chronic infections. J Immunoassay Immunochem. 2016;37:439–52.CrossRefPubMed
Metadata
Title
Basic Investigations in Pediatric Rheumatology
Authors
Aaqib Zaffar Banday
Rahila Nisar
Pratap Kumar Patra
Imtiyaz Ahmad
Anju Gupta
Publication date
07-09-2023